Our Vision
“
"Fontridge Pharmaceutical goal is to develop groundbreaking immunotherapies for cancers and infectious diseases. Our approach focuses on generating a therapeutic immune response in these patients by unleashing the natural power of a patient’s immune system to recognize and destroy tumors or virally infected cells. It is well-established that one fundamental driver of an effective immune response is T cell recognition of abnormal cells and the proliferation of sufficient quantities of T cells to drive a potent attack against these cells, whether they are cancerous or virally infected."
Individualized
Many tumor mutations are unique to each individual patient. For patients with neoantigens arising from patient-specific mutations, we believe that an immunotherapy made specifically for each patient has the potential to drive a potent immune response.
Off-the-Shelf
Some cancer mutations, known as driver mutations, recur between different cancer patients. Neoantigens that arise from these driver mutations and are shared between selected patients may be able to be used for an off-the-shelf neoantigen therapy.
LIFESTYLE CHANGES TO MANAGE A URINARY TRACT INFECTION (UTI)
Urinary tract infections (UTIs) are very common, particularly in women. Around one in two women and one in 20 men will get a UTI in their lifetime. The urinary ...
PROVEN HEALTH BENEFITS OF GARLIC
Here Are 10 Health Benefits Of Garlic That Are Supported By Human Research. 1. Garlic Contains Compounds With Potent Medicinal Properties Garlic is a pla ...